| Leroy Physical Therapy And Athletic Training, Pllc | |
|
3 West Avenue, Leroy, NY 14482 | |
| (585) 768-4550 | |
| (585) 768-2335 |
| Full Name | Leroy Physical Therapy And Athletic Training, Pllc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 3 West Avenue, Leroy, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154475739 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Nancy K Redick |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1376502856 PECOS PAC ID: 1759354863 Enrollment ID: I20040817000780 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | Leah Gerenski |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275508509 PECOS PAC ID: 5991754764 Enrollment ID: I20050119000439 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | Patrick S Privatera |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1750459442 PECOS PAC ID: 0345226031 Enrollment ID: I20050429000276 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | Craig D Rigney |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1699814939 PECOS PAC ID: 1951340348 Enrollment ID: I20050429000291 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | Keith A Bailey |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1952398315 PECOS PAC ID: 4789612342 Enrollment ID: I20050803001099 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | Erica B Cutspec |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1386976793 PECOS PAC ID: 7416089412 Enrollment ID: I20100709000095 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | Polly Ann Welch |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1710233614 PECOS PAC ID: 8820248966 Enrollment ID: I20131202000008 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | Jamie E Mazza |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255787586 PECOS PAC ID: 8628351855 Enrollment ID: I20170213001501 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | Kristyn L Radford |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1548788649 PECOS PAC ID: 5890055305 Enrollment ID: I20180201000551 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | Madison B Peitz |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1134777550 PECOS PAC ID: 1658600804 Enrollment ID: I20200505002921 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | Ellen Frances Key |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1417554841 PECOS PAC ID: 0840600672 Enrollment ID: I20201106001774 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | John A Salvas |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1417408030 PECOS PAC ID: 3375920382 Enrollment ID: I20220512002374 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | Ian Lewis Wissick |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1477281863 PECOS PAC ID: 5395120463 Enrollment ID: I20220912000342 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | Spenser L Lincoln |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1699403097 PECOS PAC ID: 4284019878 Enrollment ID: I20220919000507 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Provider Name | David Mackey |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1700669413 PECOS PAC ID: 1456715424 Enrollment ID: I20230908001869 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leroy Physical Therapy And Athletic Training, Pllc 3 West Avenue, Leroy, NY 14482 Ph: (585) 768-4550 | Leroy Physical Therapy And Athletic Training, Pllc 3 West Avenue, Leroy, NY 14482 Ph: (585) 768-4550 |
News Archive
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
Dow Jones Newswires/The Wall Street Journal reports that House Democrats who favor a government-run public insurance plan on Tuesday signaled "they are willing to agree to a final health overhaul bill without a government-run health insurance option if other parts of the bill would fulfill the same goals."
Much attention has focused on school meals, both in the United States and across the globe. Researchers at Uppsala University, Sweden, evaluated teachers eating lunch with the school children.
The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component of the President's overall public-health-focused food safety framework for maintaining a safe food supply.
InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.
› Verified 4 days ago
Mrs. Stacy Lynn Wentworth, PT Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 3 West Ave, Leroy, NY 14482 Phone: 585-768-4550 Fax: 585-768-2335 | |
Mr. Patrick Steven Privatera, PT ATC Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3 West Ave, Leroy, NY 14482 Phone: 585-768-4550 Fax: 585-768-2335 |